Vertex Pharmaceuticals Statistics
Total Valuation
VRTX has a market cap or net worth of $113.59 billion. The enterprise value is $102.58 billion.
| Market Cap | 113.59B |
| Enterprise Value | 102.58B |
Important Dates
The last earnings date was Monday, May 4, 2026, after market close.
| Earnings Date | May 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VRTX has 253.81 million shares outstanding. The number of shares has decreased by -0.15% in one year.
| Current Share Class | 253.81M |
| Shares Outstanding | 253.81M |
| Shares Change (YoY) | -0.15% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 0.21% |
| Owned by Institutions (%) | 94.56% |
| Float | 253.02M |
Valuation Ratios
The trailing PE ratio is 26.54 and the forward PE ratio is 22.85. VRTX's PEG ratio is 1.82.
| PE Ratio | 26.54 |
| Forward PE | 22.85 |
| PS Ratio | 9.30 |
| Forward PS | 8.35 |
| PB Ratio | 5.87 |
| P/TBV Ratio | 6.36 |
| P/FCF Ratio | 30.61 |
| P/OCF Ratio | 26.79 |
| PEG Ratio | 1.82 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.59, with an EV/FCF ratio of 27.65.
| EV / Earnings | 23.64 |
| EV / Sales | 8.40 |
| EV / EBITDA | 20.59 |
| EV / EBIT | 21.39 |
| EV / FCF | 27.65 |
Financial Position
The company has a current ratio of 3.02, with a Debt / Equity ratio of 0.10.
| Current Ratio | 3.02 |
| Quick Ratio | 2.38 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.38 |
| Debt / FCF | 0.54 |
| Interest Coverage | 360.53 |
Financial Efficiency
Return on equity (ROE) is 24.20% and return on invested capital (ROIC) is 28.57%.
| Return on Equity (ROE) | 24.20% |
| Return on Assets (ROA) | 12.14% |
| Return on Invested Capital (ROIC) | 28.57% |
| Return on Capital Employed (ROCE) | 21.21% |
| Weighted Average Cost of Capital (WACC) | 5.81% |
| Revenue Per Employee | $1.91M |
| Profits Per Employee | $677,859 |
| Employee Count | 6,400 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 3.56 |
Taxes
In the past 12 months, VRTX has paid $827.40 million in taxes.
| Income Tax | 827.40M |
| Effective Tax Rate | 16.02% |
Stock Price Statistics
The stock price has increased by +0.55% in the last 52 weeks. The beta is 0.30, so VRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +0.55% |
| 50-Day Moving Average | 438.67 |
| 200-Day Moving Average | 436.07 |
| Relative Strength Index (RSI) | 57.99 |
| Average Volume (20 Days) | 1,317,314 |
Short Selling Information
The latest short interest is 4.46 million, so 1.76% of the outstanding shares have been sold short.
| Short Interest | 4.46M |
| Short Previous Month | 4.17M |
| Short % of Shares Out | 1.76% |
| Short % of Float | 1.76% |
| Short Ratio (days to cover) | 3.97 |
Income Statement
In the last 12 months, VRTX had revenue of $12.22 billion and earned $4.34 billion in profits. Earnings per share was $16.86.
| Revenue | 12.22B |
| Gross Profit | 6.65B |
| Operating Income | 4.80B |
| Pretax Income | 5.17B |
| Net Income | 4.34B |
| EBITDA | 4.98B |
| EBIT | 4.80B |
| Earnings Per Share (EPS) | $16.86 |
Balance Sheet
The company has $7.25 billion in cash and $1.99 billion in debt, with a net cash position of $11.01 billion or $43.38 per share.
| Cash & Cash Equivalents | 7.25B |
| Total Debt | 1.99B |
| Net Cash | 11.01B |
| Net Cash Per Share | $43.38 |
| Equity (Book Value) | 19.36B |
| Book Value Per Share | 76.18 |
| Working Capital | 7.85B |
Cash Flow
In the last 12 months, operating cash flow was $4.24 billion and capital expenditures -$530.30 million, giving a free cash flow of $3.71 billion.
| Operating Cash Flow | 4.24B |
| Capital Expenditures | -530.30M |
| Depreciation & Amortization | 186.10M |
| Net Borrowing | -5.40M |
| Free Cash Flow | 3.71B |
| FCF Per Share | $14.62 |
Margins
Gross margin is 54.39%, with operating and profit margins of 39.25% and 35.51%.
| Gross Margin | 54.39% |
| Operating Margin | 39.25% |
| Pretax Margin | 42.28% |
| Profit Margin | 35.51% |
| EBITDA Margin | 40.77% |
| EBIT Margin | 39.25% |
| FCF Margin | 30.37% |
Dividends & Yields
VRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.15% |
| Shareholder Yield | 0.15% |
| Earnings Yield | 3.82% |
| FCF Yield | 3.27% |
Analyst Forecast
The average price target for VRTX is $548.69, which is 22.60% higher than the current price. The consensus rating is "Buy".
| Price Target | $548.69 |
| Price Target Difference | 22.60% |
| Analyst Consensus | Buy |
| Analyst Count | 33 |
| Revenue Growth Forecast (5Y) | 9.60% |
| EPS Growth Forecast (5Y) | 15.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 24, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 24, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
VRTX has an Altman Z-Score of 11.73 and a Piotroski F-Score of 6.
| Altman Z-Score | 11.73 |
| Piotroski F-Score | 6 |